Sugar’s Vineeta Singh: 'Shark' who built $500-mILLIOn firm that saw its losses jump 3x

Vineeta Singh is one of the most-talked about investors in the Indian business reality show, Shark Tank India, where she has returned as a 'shark' for season 2

Vineeta Singh, the 'shark'

Vineeta Singh hit headlines after she refused a Rs 1 crore per annum offer immediately after completing her MBA from IIM Ahmedabad

Vineeta Singh's initial


Sugar Cosmetics is Vineeta Singh's second venture. Her first venture was called Fab Bag. While working on this start-up she realised there was a gap in the cosmetics market. After Fab Bag failed to make a mark, Vineeta Singh launched Sugar in 2012

Not a stranger to failures

Vineeta Singh has often shared her struggles and her journey of not getting funding in the initial years of starting Sugar Cosmetics because she was a woman entrepreneur

Toiling her way up

"Investors refused to fund Sugar until my husband joined it," Vineeta Singh said about her initial struggles as a woman entrepreneur

'Investors refused to fund

Sugar until...'

Today, Vineeta Singh is lauded for building a company like Sugar Cosmetics, which has a valuation close to $500 million

Scaling up Sugar

“I am going to miss Ashneer Grover, I think he was good. But whatever happened was between him and the channel," said Vineeta about her fellow judge Grover's absence from season 2

Vineeta Singh on Ashneer

Grover's absence

In the initial episodes of Shark Tank India, Singh was trolled for rejecting the pitch of a cosmetics brand, Recode because it was a rival brand

Under the scanner of


Vineeta Singh’s credentials as a ‘shark’ were also questioned after the financials of the company came into the limelight. In FY22, Sugar’s losses jumped by 3.6x, standing at Rs 76.2 crore

Running a loss-making


Men earning over Rs 30 lakh are 190% more desirable. Here's what Indian millennials seek in their partners, as per

Produced by: Bhavya Kaushal

Designed by: Mohsin Next Visual Story 

Next: Adani Under Attack: Adani Group stocks plummet after Nathan Anderson’s Hindenburg report. What’s beyond the bloodbath?